🟢 Bayer Aktiengesellschaft is trading 4.8% up today following a favorable Roundup settlement ruling and the completion of Perfuse Therapeutics acquisition

Bayer Aktiengesellschaft is trading at $37.74 (+4.80%) following several key developments on June 17, 2026, including a broader market rally.

• A federal judge sent Bayer's proposed $7.25 billion Roundup class action settlement back to Missouri state court, a move seen as a victory for Bayer.
• Bayer also completed the acquisition of Perfuse Therapeutics Inc. for up to $2.45 billion, strengthening its ophthalmology pipeline.